Finance

Lists
Q910:FRA
Annexin Pharmaceuticals AB (publ)
€ 1.20
+4.37%
(+0.050) 1D
9-р сарын 8, 08:13:52 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for Q910...
Open
€ 1.20
High
€ 1.20
Low
€ 1.20
Mkt. cap
117.70 сая
Avg. vol.
192.00
Volume
0.00
52-wk high
€ 2.60
52-wk low
€ 1.02
No. of employees
4
Open
€ 1.20
High
€ 1.20
Low
€ 1.20
Mkt. cap
117.70 сая
Avg. vol.
192.00
Volume
0.00
52-wk high
€ 2.60
52-wk low
€ 1.02
No. of employees
4
About Annexin Pharmaceuticals AB (publ)
CEO-
Employees4
Founded2014
Headquarters-
SectorPharmaceutical industry
Websiteannexinpharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.05 сая
8.00 сая
7.92 сая
8.48 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.35 сая
2.26 сая
2.90 сая
2.96 сая
Operating expense
9.40 сая
10.26 сая
10.82 сая
11.56 сая
Total operating expenses
9.40 сая
10.26 сая
10.82 сая
11.56 сая
Operating income
-9.40 сая
-10.26 сая
-10.82 сая
-11.56 сая
Other non operating income
-
-
-
1.00 мян.
EBT including unusual items
-9.90 сая
-10.52 сая
-10.52 сая
-11.56 сая
EBT excluding unusual items
-9.90 сая
-10.52 сая
-10.52 сая
-11.56 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
127.00 мян
Net income
-9.90 сая
-10.52 сая
-10.52 сая
-11.56 сая
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
154.00 мян
231.00 мян
34.00 мян
-
Interest expense
-
-
-
-
Net interest expenses
154.00 мян
231.00 мян
34.00 мян
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.35 сая
-10.21 сая
-10.77 сая
-11.51 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс